Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Forecasted for the Quit Smoking Drugs Market over the 2024-2033 Period?
Recent years have seen a swift expansion in the market size of quit smoking drugs. The growth is expected to continue, rising from $34.86 billion in 2023 to $39.69 billion in 2024, marking a compound annual growth rate (CAGR) of 13.8%. Factors contributing to this growth in the historic period include health awareness campaigns, advances in medical science, government efforts, the incorporation of behavioral therapies, as well as a change in consumer attitudes.
The market size of anti-smoking medications is predicted to expand quickly in the upcoming years, escalating to $69.08 billion in 2028 with a compound annual growth rate (CAGR) of 14.9%. The predicted growth for the forecast period is due to factors such as investment in research and development, increase in demand for cessation aids, targeted advertising and awareness drives, and improvements in pharmacotherapy. Notable trends for the forecast period are individualized treatment strategies, heightened health awareness, digital therapeutic solutions and applications, integration of behavioral therapy, targeted promotion and education.
Claim Your Free Sample of the Global Quit Smoking Drugs Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9247&type=smp
Which Factors Are Stimulating Growth in the quit smoking drugs Market?
The increasing incidence of various illnesses linked to smoking is predicted to fuel the expansion of the market for quitting smoking drugs. The act of inhaling and exhaling the fumes from burning plant substances like marijuana, hashish, tobacco, and the like is known as smoking. Drugs that aid in quitting smoking work by diminishing an individual’s desire for tobacco, and are typically prescribed to help manage withdrawal symptoms from nicotine, thereby aiding in successfully quitting smoking. For example, the World Health Organization (WHO), a Switzerland-based global public health entity, reported in May 2022 that tobacco will kill more than 8 million people annually. Exposure to secondhand smoke leads to around 1.2 million of these deaths, while more than 7 million are caused from direct tobacco use. In addition, the American Heart Association, a nonprofit organization in the US, reported in 2021 that over 480,000 adults die in the United States each year from heart disease caused by smoking. Thus, the increasing incidence of various diseases attributable to smoking is fuelling the expansion of the quit-smoking drug market.
What Are the Main Segments of the Quit Smoking Drugs Market?
1) By Product: Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
2) By Drug: Varenicline (Chantix), Bupropion (Zyban), Other Drugs
3) By Distribution: Drug Store, Online Pharmacies, Retail Pharmacies
What Innovative Trends Are Redefining the Quit Smoking Drugs Landscape?
The development of unique and innovative products is a main trend in the quit-smoking drug industry in efforts to gain traction in the market. Major companies in this sector are focusing on pioneering new products to solidify their market standing. For example, in August 2022, Swedish Match AB, a tobacco company based in Sweden, introduced ZYN Tobacco Gold, a tobacco-flavored nicotine pouch for the travel retail market. The Tobacco Gold pouches are offered in medium (3 mg) and strong (6 mg) variants. The pouches deliver a sweet tobacco taste, characterized by hints of dried fruit, wood, and caramel which satisfies many consumers, given that tobacco is the leading flavor that aids consumers in choosing lower-risk alternatives that are both devoid of tobacco and smoke. This product presents a viable solution for individuals who wish to quit using tobacco while also enjoying a nicotine experience in non-smoking environments.
Order Now for Fast Delivery of Your Quit Smoking Drugs Market Report!
https://www.thebusinessresearchcompany.com/report/quit-smoking-drugs-global-market-report
Which Regions Are Key Players in the Growth of the Quit Smoking Drugs Market?
North America was the largest region in the quit smoking drugs market in 2023. The regions covered in the quit smoking drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Quit Smoking Drugs Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the quit smoking drugs market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Quit Smoking Drugs Market Include
1. Quit Smoking Drugs Market Executive Summary
2. Quit Smoking Drugs Market Segments
3. Quit Smoking Drugs Market Size And Template Market Growth Rate
4. Key Quit Smoking Drugs Market Trends
5. Major Quit Smoking Drugs Market Drivers
……
25. Key Mergers And Acquisitions In The Quit Smoking Drugs Market
26. Top Quit Smoking Drugs Companies
27. Quit Smoking Drugs Market Opportunities And Strategies
28. Quit Smoking Drugs Market, Conclusions And Recommendations
29. Appendix
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
